WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL MEETING VOTING RESULTS

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL MEETING VOTING RESULTS

Canada NewsWire

VANCOUVER, BC, May 13, 2022 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general meeting of shareholders held on May 13, 2022 (the "Meeting"). A total of 42,387,564 common shares, representing approximately 34.31% of the Company's issued and outstanding shares were represented at the meeting.

The following nominees were elected as directors of Willow for the ensuing year with the specific voting results being as follows:


Votes For

Votes Withheld

Director

#

%

#

%

Dr. Peter Seufer-Wasserthal

36,177,987

99.18%

300,231

0.82%

Trevor Peters

36,166,230

99.14%

311,988

0.86%

Dr. Fotis Kalantzis

35,666,513

97.77%

811,705

2.23%

Donald Archibald

36,092,217

98.94%

386,001

1.06%

Sadiq H. Lalani

35,671,203

97.79%

807,015

2.21%

Al Foreman

35,867,631

98.33%

610,587

1.67%

Barbara Munroe

36,160,678

99.13%

317,540

0.87%

In addition, shareholders approved the appointment of KPMG LLP as the Company's auditor for the ensuing year (99.99% of the votes cast being in favour). For complete voting results on all matters approved at the Meeting, please see the Company's Report of Voting Results dated May 13, 2022 available on SEDAR at www.sedar.com.

About Willow Biosciences Inc.

Willow is a leading biotechnology company that develops and produces high-purity, plant derived ingredients for the personal care, food and beverage, and pharmaceutical markets. Willow's FutureGrown™ biotechnology platform allows large-scale production of pure, consistent, and sustainable products to benefit our B2B partners and their customers.

SOURCE Willow Biosciences Inc.

Cision View original content: http://www.newswire.ca/en/releases/archive/May2022/13/c2540.html

Copyright CNW Group 2022

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).